6.99
Cullinan Therapeutics Inc Azioni (CGEM) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
|
37.82%
75.80
|
55.00 | 48.85 | 50.03 | 42.99 |
Operating Income/Loss |
37.82%
-75.80
|
-55.00 | -48.85 | -50.03 | -42.99 |
Income/Loss From Continuing Operations Before Tax |
44.44%
-70.06
|
-48.50 | -40.56 | -42.03 | -37.34 |
Income/Loss From Continuing Operations After Tax |
44.44%
-70.06
|
-48.50 | -40.56 | -42.03 | -37.34 |
|
44.44%
-70.06
|
-48.50 | -40.56 | -42.03 | -37.34 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | -0.192 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):